Categories Earnings, Retail

Burlington Stores’ stock soars 7% after Q3 results beat

Burlington Stores Inc. (BURL) beat market estimates on revenue and earnings for the third quarter of 2018 and raised its full-year outlook. The stock rose 7.7% during premarket hours on Wednesday.

burlington stores third quarter 2018 earnings results
(Image Courtesy: Pixabay)

Total revenue was $1.64 billion compared to $1.44 billion in the same period last year. Of this, net sales amounted to $1.63 billion, reflecting a growth of 13.7% from last year. Comparable store sales increased 4.4% versus 3.1% last year.

GAAP net income grew 71% year-over-year to $77 million, or $1.12 per share. Adjusted net income rose 70% to $83 million, or $1.21 per share.

For the full year of 2018, total sales are expected to increase in the range of 10.9% to 11.2%, excluding the 53rd week impact in 2017. This guidance assumes an increase of 2-3% in shifted comparable store sales for the fourth quarter of 2018, resulting in a full-year shifted comparable store sales increase of 3.4% to 3.7%.

Macy’s Q3 profit jumps 107%, beats estimates

Adjusted EPS for 2018 is now expected to be $6.33 to $6.37 versus the previous outlook of $6.13 to $6.20. Adjusted EPS, excluding the impact of the tax reform, the accounting for share-based compensation and the revaluation of deferred tax liabilities, is expected to grow 21-22% and come in a range of $5.01 to $5.05.

For the fourth quarter of 2018, total sales are expected to grow 8% to 9% while shifted comparable sales are expected to grow 2% to 3%. Adjusted EPS is expected to come in a range of $2.71 to $2.75.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top